04:12 PM EDT, 06/18/2025 (MT Newswires) -- Jeffrey S Farrow, Chief Financial Officer and Chief Strategy Officer, on June 16, 2025, sold 13,608 shares in Tarsus Pharmaceuticals ( TARS ) for $550,035. Following the Form 4 filing with the SEC, Farrow has control over a total of 36,704 common shares of the company, with 36,704 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1819790/000181979025000102/xslF345X05/wk-form4_1750277272.xml